Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 5Thoracic 3Other solid neoplasm 3Lymphoid 2Other hematologic neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Wilms Tumor 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioma 2Ependymoma 2Central Nervous System Neoplasms 2Xanthogranuloma, Juvenile 1Urinary Bladder Neoplasms 1Sarcoma, Synovial 1Mesothelioma, Malignant 1Hodgkin Disease 1Histiocytic Sarcoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1

Interventions

fludarabine 2Ifosfamide 2Filgrastim 2Doxorubicin 2Cyclophosphamide 2tazemetostat 1pembrolizumab 1lorvotuzumab mertansine 1ixabepilone 1cixutumumab 1Radiotherapy 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Drug Therapy 1Chemotherapy, Adjuvant 1CLR1404 1Biological Therapy 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × tazemetostat × Genitourinary × Clear all
NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available
GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡